Investors Purchase High Volume of Call Options on Aurora Cannabis (NASDAQ:ACB)

Aurora Cannabis Inc. (NASDAQ:ACB) was the recipient of some unusual options trading activity on Friday. Stock traders purchased 4,076 call options on the company. This represents an increase of 60% compared to the typical daily volume of 2,552 call options.

Institutional Investors Weigh In On Aurora Cannabis

Several large investors have recently made changes to their positions in ACB. Susquehanna Fundamental Investments LLC acquired a new stake in Aurora Cannabis in the third quarter valued at approximately $100,000. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Aurora Cannabis by 1,808.9% in the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 10,518 shares of the company’s stock valued at $63,000 after purchasing an additional 9,967 shares during the last quarter. Millennium Management LLC boosted its holdings in Aurora Cannabis by 563.7% in the third quarter. Millennium Management LLC now owns 391,782 shares of the company’s stock worth $2,339,000 after purchasing an additional 332,750 shares in the last quarter. Two Sigma Investments LP increased its position in Aurora Cannabis by 7,412.0% during the third quarter. Two Sigma Investments LP now owns 1,149,869 shares of the company’s stock worth $6,853,000 after buying an additional 1,134,562 shares during the last quarter. Finally, UBS Group AG lifted its position in shares of Aurora Cannabis by 136.8% in the third quarter. UBS Group AG now owns 184,190 shares of the company’s stock worth $1,098,000 after buying an additional 106,391 shares during the last quarter. Institutional investors own 47.63% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently commented on the stock. Zacks Research raised shares of Aurora Cannabis from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Weiss Ratings reissued a “sell (d-)” rating on shares of Aurora Cannabis in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold”.

Aurora Cannabis Stock Up 18.7%

NASDAQ ACB opened at $5.40 on Friday. The stock has a market cap of $306.07 million, a PE ratio of -7.83 and a beta of 0.24. The company has a quick ratio of 1.63, a current ratio of 3.41 and a debt-to-equity ratio of 0.06. The business has a 50 day moving average price of $4.85 and a two-hundred day moving average price of $4.93. Aurora Cannabis has a fifty-two week low of $3.42 and a fifty-two week high of $6.91.

Aurora Cannabis (NASDAQ:ACB) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.03 by $0.06. The business had revenue of $64.88 million for the quarter, compared to analysts’ expectations of $86.45 million. Aurora Cannabis had a negative net margin of 15.96% and a negative return on equity of 0.58%. As a group, sell-side analysts predict that Aurora Cannabis will post 0.46 EPS for the current fiscal year.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.